These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7197020)

  • 1. Does a rhythmicity of serum concentrations and urinary excretion of dipyridamole exist during long-term treatment?
    Markiewicz A; Semenowicz K
    Pol J Pharmacol Pharm; 1980; 32(3):289-95. PubMed ID: 7197020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bioavailability of two dipyridamole formulations.
    Markiewicz A; Semenowicz K; Szczyrba E; Kocek B
    Pol J Pharmacol Pharm; 1978; 30(5):605-9. PubMed ID: 582068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bioavailability of three dipyridamole products.
    Markiewicz A; Hartleb M; Boldys H
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):499-501. PubMed ID: 6642785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacokinetics of dipyridamole.
    Markiewicz A; Semenowicz K; Korczynska J; Czachowska A
    Int J Clin Pharmacol Biopharm; 1979 May; 17(5):222-4. PubMed ID: 468446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An evaluation of the efficacy of chronotheray with heparin and kurantil in patients with chronic pyelonephritis].
    Zaslavskaia RM; Agzamova RT; Teĭblium TM
    Eksp Klin Farmakol; 1995; 58(1):40-2. PubMed ID: 7787695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
    Khajehdehi P; Roozbeh J; Mostafavi H
    Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of dipyridamole in blood components among post-stroke patients treated with extended release formulation.
    Serebruany V; Sabaeva E; Booze C; Atar OD; Eisert C; Hanley D;
    Thromb Haemost; 2009 Sep; 102(3):538-43. PubMed ID: 19718475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of high doses of atropine during dipyridamole echocardiography: safety and efficacy of the combined test].
    Coletta C; Greco G; Galati A; Ricci R; Ceci V
    G Ital Cardiol; 1995 Nov; 25(11):1389-98. PubMed ID: 8682234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of dipyridamole.
    Bjornsson TD; Mahony C
    Thromb Res Suppl; 1983; 4():93-104. PubMed ID: 6579711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oral dipyridamole electrocardiography test in ischaemic heart disease.
    Gupta PR; Avashty P; Garg AK; Prasad PV
    J Assoc Physicians India; 1997 Nov; 45(11):860-2. PubMed ID: 11229186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate.
    Tryba M; Kurz-Müller K; Donner B
    Crit Care Med; 1994 Nov; 22(11):1769-73. PubMed ID: 7956280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous dipyridamole in acute cerebral infarct. Is it efficacious?].
    Millán-Guerrero R; Isais-Cárdenas M
    Gac Med Mex; 1999; 135(4):391-6. PubMed ID: 10491894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased soluble VCAM-1 serum levels in preeclampsia are not correlated to urinary excretion or circadian blood pressure rhythm.
    Heyl W; Heintz B; Reister F; Harwig S; Witte K; Lemmer B; Rath W
    J Perinat Med; 2005; 33(2):144-8. PubMed ID: 15843265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persantine bioavailability problems.
    Lehmann CR; Locke K; Pierson WP; Shaffer PJ; Hall W
    Clin Pharm; 1984; 3(1):14-5. PubMed ID: 6697671
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study.
    Sanada S; Asanuma H; Koretsune Y; Watanabe K; Nanto S; Awata N; Hoki N; Fukunami M; Kitakaze M; Hori M
    Hypertens Res; 2007 Oct; 30(10):913-9. PubMed ID: 18049022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipyridamole induces interferon in man.
    Galabov AS; Mastikova M
    Biomed Pharmacother; 1984; 38(8):412-3. PubMed ID: 6084526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study.
    Bae JH; Oh MM; Shim KS; Cheon J; Lee JG; Kim JJ; Moon DG
    J Urol; 2007 Jul; 178(1):200-3. PubMed ID: 17499799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.